NCDs

Lilly Collaborates to Fight NCDs in South Africa

Multimedia with summary

Lilly Collaborates to Fight NCDs in South Africa

by Karen Van der Westhuizen, Communication Manager of Lilly’s Global Health Programs.

The Lilly NCD Partnership is one of Lilly’s flagship corporate responsibility initiatives. Launched in late 2011, the partnership works in four countries (Brazil, India, Mexico and South Africa) to research innovative ways to tackle non-communicable diseases (NCDs),specifically diabetes.

Novo Nordisk Partners with Ministry of Health to Prevent Diabetes

Novo Nordisk and the Malaysian Ministry of Health are taking steps to prevent diabetes with a partnership encouraging young couples to adopt healthier habits - before they begin having children.
Press Release

November 14, 2012 /3BL Media/ - Today, Novo Nordisk entered into a public private partnership with the Malaysian Ministry of Health to prevent diabetes through a health promotion programme targeting young couples. The Jom Mama programme builds on research showing that women entering pregnancy overweight or obese increases the risk of developing non-communicable diseases, including type 2 diabetes, in both mother and child in later years of life.

One-Year Anniversary of United Nations Meeting on NonCommunicable Diseases Leading Health Organizations Cite Progress

Press Release

(3BL Media) Washington, DC – September 25, 2012 – One year ago today, the United Nations held a High-Level Meeting on non-communicable Diseases. Only the second meeting ever convened by the U.N. on a health issue, the conference was attended by John Seffrin, Ph.D., CEO of the American Cancer Society; Larry Hausner, CEO of the American Diabetes Association; and Nancy Brown, CEO of the American Heart Association.

LillyPad, Our Company Blog: Improving Lives, Improving Lilly – Shared Value in Action

Blog

September 14, 2011 | By: David Marbaugh

You may have seen me or Rob Smith blogging about shared value and how it’s the wave of the future for corporate responsibility. And you may have thought, “OK, Sounds good. But why the heck do they keep going on about it?”

Video: Lilly Joins Global Fight to Combat Non-Communicable Diseases in Developing Countries

Summary: 

Through The Lilly NCD Partnership, we are investing $30 million to fight the rising burden of non-communicable diseases in developing countries. We invite you to watch our video. Then learn more at http://elil.ly/1u7z.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

LILLY16727

Press Release

Through The Lilly NCD Partnership, we are investing $30 million to fight the rising burden of non-communicable diseases in developing countries. We invite you to watch our video. Then learn more at http://elil.ly/1u7z.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

LILLY16727

Lilly Invests $30 Million in Partnership to Address Non-Communicable Diseases

The Lilly NCD Partnership will seek innovative solutions to help fight chronic diseases in developing countries
Press Release

(3BL Media / theCSRfeed) Indianapolis, IN - September 14, 2011 - Eli Lilly and Company (NYSE: LLY) announced today a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations. Lilly is launching The Lilly NCD Partnership, which combines the company’s unique resources with the expertise of leading global health organizations, to identify new models of patient care that increase treatment access and improve outcomes for underserved people.

How Private Healthcare Can Solve Noncommunicable Diseases: Washington Post Live Conference

LIVE Conference Webcast, 9/14 at 8:30 a.m.
Summary: 

FSG's Mark Kramer, Founder and Managing Director, will join leading public health experts to discuss the best ways to solve the growing health crisis of Noncommunicable Diseases (NCDs) such as diabetes, heart disease, and cancer.  The September 14th conference, Sharing the Responsibility: Noncommunicable Diseases, will address how private health care companies, governments and nonprofits can join forces to curb the alarming rise worldwide of people suffering NCDs.

Sharing the Responsibility: Noncommunicable Diseases: September 14th, 8:30 a.m.-2:00 p.m.

Press Release

FSG's Mark Kramer, Founder and Managing Director, will join leading public health experts to discuss the best ways to solve the growing health crisis of Noncommunicable Diseases (NCDs) such as diabetes, heart disease, and cancer.  The September 14th conference, Sharing the Responsibility: Noncommunicable Diseases, will address how private health care companies, governments and nonprofits can join forces to curb the alarming rise worldwide of people suffering NCDs.

Sharing the Responsibility: Noncommunicable Diseases: September 14th, 8:30 a.m.-2:00 p.m.

Global Health Issues

Podcast series on the Noncommunicable Disease Health Challenge Facing the World
Summary: 

 

Noncommunicable diseases (NCDs) accounted for 63% of global deaths in 2008 -- 36 million people. NCD deaths are projected to increase by 15% globally between 2010 and 2020 – to 44 million. In this podcast series, Medtronic executives discuss how collaboration between the public and private sector is key to alleviating this global issue.
summary

 

Noncommunicable diseases (NCDs) accounted for 63% of global deaths in 2008 -- 36 million people. NCD deaths are projected to increase by 15% globally between 2010 and 2020 – to 44 million. In this podcast series, Medtronic executives discuss how collaboration between the public and private sector is key to alleviating this global issue.

Pages

Subscribe to NCDs